Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

3421. Screening surgeons for HIV infection: a cost-effectiveness analysis

Screening surgeons for HIV infection: a cost-effectiveness analysis Screening surgeons for HIV infection: a cost-effectiveness analysis Screening surgeons for HIV infection: a cost-effectiveness analysis Owens D, Harris R A, Scott P M, Nease R F Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology HIV infection screening of surgeons. Type of intervention Secondary prevention, screening. Economic study type Cost-effectiveness analysis. Study population A hypothetical cohort of surgeons. Setting Hospital. The economic study was carried out in California, USA. Dates to which data relate The main effectiveness data were obtained from publications over the period 1986-1992. Cost data were estimated from data between 1989-1994.1993

NHS Economic Evaluation Database.1995

3422. Screening for colorectal cancer: what are the costs?

Screening for colorectal cancer: what are the costs? Screening for colorectal cancer: what are the costs? Screening for colorectal cancer: what are the costs? Weller D, Moss J, Hiller J, Thomas J, Edwards J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study (...) and the conclusions drawn. Health technology The fecal occult blood test (FOBT) as a method for screening for the detection of colorectal cancer. Type of intervention Screening. Economic study type Cost-effectiveness study. Study population Patients screened for colorectal cancer. Setting The practice setting is the community with follow up in general practice and institutions as required. The study was undertaken in South Australia. Dates to which data relate Effectiveness and resource data were collected

NHS Economic Evaluation Database.1995

3423. Increasing Medicaid child health screenings: the effectiveness of mailed pamphlets, phone calls, and home visits

Increasing Medicaid child health screenings: the effectiveness of mailed pamphlets, phone calls, and home visits Increasing Medicaid child health screenings: the effectiveness of mailed pamphlets, phone calls, and home visits Increasing Medicaid child health screenings: the effectiveness of mailed pamphlets, phone calls, and home visits Selby-Harrington M, Sorenson J R, Quade D, Stearns S C, Tesh A S, Donat P L Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Medicaid child health screenings using mailed pamphlets, phone calls and home visits. Type of intervention Primary prevention - screening. Economic study type Cost-effectiveness analysis. Study population Children from birth to age 21 who are eligible for Medicaid

NHS Economic Evaluation Database.1995

3424. [Evaluation of the costs of mammographic screening programme in the city of Florence]

[Evaluation of the costs of mammographic screening programme in the city of Florence] La valutazione dei costi del programma di screening mammografico nella citta di Firenze [Evaluation of the costs of mammographic screening programme in the city of Florence] La valutazione dei costi del programma di screening mammografico nella citta di Firenze [Evaluation of the costs of mammographic screening programme in the city of Florence] Spagnolo G, Zappa M, Paci E, Giorgi D, Rosselli del Turco M (...) Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening programme for breast cancer detection. Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis. Study population The population under study

NHS Economic Evaluation Database.1995

3425. Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation

Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation Kiberd B A, Jindal K K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Strategies to prevent the development of end stage renal disease. Strategy A: Early screening, testing for microalbuminuria. Two positive tests out of three (>20 micrograms/minute) were followed by treatment with an angiotensin converting enzyme inhibitor. Strategy B: No testing for microalbuminuria, same treatment as strategy A in patients with hypertension

NHS Economic Evaluation Database.1995

3426. The cost-effectiveness of mammographic screening strategies

The cost-effectiveness of mammographic screening strategies The cost-effectiveness of mammographic screening strategies The cost-effectiveness of mammographic screening strategies Lindfors K K, Rosenquist J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study (...) and the conclusions drawn. Health technology Mammographic screening for breast cancer. A total of seven strategies were considered: (1)annual mammography for ages 40 to 79 years; (2)annual mammography for ages 50 to 79 years; (3) biennial mammography for ages 50 to 79 years; (4)annual mammography for ages 40 to 49 years with biennial mammography for ages 50 to 79 years; (5)annual mammography for ages 40 to 64 years with biennial mammography for age 65 to 79 years; (6)biennial mammography for ages 40 to 49 years

NHS Economic Evaluation Database.1995

3427. Cost-benefit analysis of screening for toxoplasmosis during pregnancy

Cost-benefit analysis of screening for toxoplasmosis during pregnancy Cost-benefit analysis of screening for toxoplasmosis during pregnancy Cost-benefit analysis of screening for toxoplasmosis during pregnancy Lappalainen M, Sintonen H, Koskiniemi M, Hedman K, Hiilesmaa V, Ammala P, Teramo K, Koskela P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening and health education versus a health education without screening option, for primary toxoplasma infections during pregnancy. Type of intervention Screening; treatment; primary prevention. Economic study type Cost-effectiveness analysis. Study population Pregnant women. Setting The practice setting was the primary care sector. The economic study was conducted

NHS Economic Evaluation Database.1995

3428. Tuberculosis screening among homeless persons with AIDS living in single-room-occupancy hotels

Tuberculosis screening among homeless persons with AIDS living in single-room-occupancy hotels Tuberculosis screening among homeless persons with AIDS living in single-room-occupancy hotels Tuberculosis screening among homeless persons with AIDS living in single-room-occupancy hotels Layton M, Cantwell M, Dorsinville G, Valway S, Onorato M, Frieden T Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains (...) a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Tuberculosis screening strategies. In particular: 1)interviewing for symptoms and tuberculosis history; 2) skin tests using the Mantoux method, and conducting anergy tests; 3) portable frontal-view radiographs. Type of intervention Screening and diagnosis. Economic study type Cost-effectiveness analysis. Study population

NHS Economic Evaluation Database.1995

3429. Benefits and costs of screening and treatment for early breast cancer: development of a basic benefit package

Benefits and costs of screening and treatment for early breast cancer: development of a basic benefit package Benefits and costs of screening and treatment for early breast cancer: development of a basic benefit package Benefits and costs of screening and treatment for early breast cancer: development of a basic benefit package Kattlove H, Liberati A, Keeler E, Brook R H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each (...) abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening and treatment strategies for early breast cancer. Type of intervention Screening and treatment. Economic study type Cost-effectiveness analysis. Study population A hypothetical health care organisation with an enrolled population of 500,000, in which 360 new cases of breast cancer would be expected

NHS Economic Evaluation Database.1995

3430. Prostate cancer screening in a large corporation population

Prostate cancer screening in a large corporation population Prostate cancer screening in a large corporation population Prostate cancer screening in a large corporation population Kantrowitz W, Doyle J, Semeraro J, Krane R J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Prostate cancer screening. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Male employees of the Polaroid Corporation aged between 50 and 65 years. Setting Occupational. A large public corporation medical department in the United States. Dates to which data relate The start date of the screening programme was unclear. Resources used and costs were presented for the actual programme. The price year

NHS Economic Evaluation Database.1995

3431. A cost-effectiveness analysis of cervical cancer screening: health policy implications

A cost-effectiveness analysis of cervical cancer screening: health policy implications A cost-effectiveness analysis of cervical cancer screening: health policy implications A cost-effectiveness analysis of cervical cancer screening: health policy implications Gyrd-Hansen D, Holund B, Andersen P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions (...) followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Cervical cancer screening programme. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Hypothetical cohort of women aged between 15 and 99 years in Denmark. Setting The economic evaluation was performed in Denmark. Dates to which data relate The effectiveness of screening data related to the period 1966 to 1982. Prices were based on 1992

NHS Economic Evaluation Database.1995

3432. Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2,400 men

Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2,400 men Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2,400 men Cost-effectiveness analysis in early detection of prostate cancer: an evaluation of six screening strategies in a randomly selected population of 2,400 men Gustafsson O, Carlsson P (...) , Norming U, Nyman C R, Svensson H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The early detection of prostate cancer: a cost-effectiveness analysis of six screening strategies using different combinations of digital rectal

NHS Economic Evaluation Database.1995

3434. UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening.

UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. 7488893 1996 01 04 1996 01 04 2016 11 23 0959-8138 311 7014 1995 Nov 04 BMJ (Clinical research ed.) BMJ UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. 1189-93 To compare one view (oblique) and two view (oblique and craniocaudal) mammography in breast cancer screening. Randomised controlled trial. Nine breast screening centres (...) in England. 40,163 women aged 50-64 attending their first breast screening examination. Women were randomised to have one view mammography, two view mammography, or two view mammography in which one view was read by one reader and both views were read by another. Prevalence of cancer detected, recall rates, cost per cancer detected, and marginal cost per extra cancer detected. Two view mammography detected 24% more women with breast cancer (95% confidence interval 16% to 31%) than one view mammography

BMJ1995 Full Text: Link to full Text with Trip Pro

3435. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.

Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening. 7866213 1995 03 30 1995 03 30 2016 10 19 0959-8138 310 6976 1995 Feb 11 BMJ (Clinical research ed.) BMJ Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening. 353-7 To perform a rigorous comparative evaluation of stepwise and couple approaches to antenatal carrier screening for cystic fibrosis. Pragmatic randomised trial. Hospital antenatal clinic (...) serving a regional population. 2002 women (couples) attending for booking antenatal visit at less than 17 weeks' gestation with no family history of cystic fibrosis. Offering counselling and carrier testing for cystic fibrosis, either to women in the first instance (stepwise) or to couples (couple screening). Uptake rates; anxiety; knowledge of cystic fibrosis and carrier status (both partners); attitudes to health, pregnancy, the baby, and screening (both partners); and uptake of carrier testing

BMJ1995 Full Text: Link to full Text with Trip Pro

3436. Screening for childhood lead poisoning: a cost-minimization analysis

Screening for childhood lead poisoning: a cost-minimization analysis Screening for childhood lead poisoning: a cost-minimization analysis Screening for childhood lead poisoning: a cost-minimization analysis Glotzer D E, Bauchner H, Freedberg K A, Palfrey S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical (...) assessment on the reliability of the study and the conclusions drawn. Health technology Screening strategies for childhood lead poisoning: (1) venipuncture; (2) capillary specimen, with venipuncture confirmation; and (3) stratification by risk, with venipuncture for high-risk children and capillary sample for low-risk children. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Children under the age of 6 years. Setting Primary care. The economic study

NHS Economic Evaluation Database.1994

3437. Incremental cost-effectiveness of incorporating oestriol evaluation in Down syndrome screening programmes

Incremental cost-effectiveness of incorporating oestriol evaluation in Down syndrome screening programmes Incremental cost-effectiveness of incorporating oestriol evaluation in Down syndrome screening programmes Incremental cost-effectiveness of incorporating oestriol evaluation in Down syndrome screening programmes Ganiats T G, Halverson A L, Bogart M H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains (...) a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Prenatal screening tests for Down Syndrome (DS). In particular the use of the 'Double test'- a combination of two maternal blood tests, human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP), with maternal age-related risk, and the 'Triple test'- a combination of three maternal blood tests, unconjugated oestriol (uE3

NHS Economic Evaluation Database.1994

3438. Small, blue collar work site hypertension screening: a cost effectiveness study

Small, blue collar work site hypertension screening: a cost effectiveness study Small, blue collar work site hypertension screening: a cost effectiveness study Small, blue collar work site hypertension screening: a cost effectiveness study Ellis E, Koblin W, Irvine M J, Legare J, Logan A G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions (...) followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology One-stage versus two-stage screening for hypertension. One-stage screening consists of a single blood pressure measurement and those with a diastolic blood pressure (DBP) of 90-99 mmHg and already on medication or DBP of 100-114 mmHg were advised to contact their physician within one month. Two-stage screening consisted of two screening tests two weeks apart, with those of high DBP

NHS Economic Evaluation Database.1994

3439. An economic rationale for prostate cancer screening

An economic rationale for prostate cancer screening An economic rationale for prostate cancer screening An economic rationale for prostate cancer screening Benoit R M, Naslund M J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health (...) technology (a) Screening for prostate cancer using prostate-specific antigen(PSA) testing with and without digital rectal examination(DRE) (b) Screening for breast cancer using mammography with and without clinical breast examination. Type of intervention Secondary prevention Economic study type Cost-effectiveness analysis. Study population Men aged 50 to 70 and women aged 50-69. Setting The practice setting for breast cancer screening was not specified (it might be primary care). Prostate cancer

NHS Economic Evaluation Database.1994

3440. The two tier fecal occult blood test: cost-effective screening

The two tier fecal occult blood test: cost-effective screening The two tier fecal occult blood test: cost-effective screening The two tier fecal occult blood test: cost-effective screening Rae A J, Cleator I G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study (...) and the conclusions drawn. Health technology Two-tier fecal occult blood test which is a strategy combining HO Sensa guaiac test and a hemoglobin-specific Hemeselect test when the result of the former is positive. Type of intervention Screening Economic study type Cost-effectiveness analysis Study population The study population included males and females 40 years of age or older. Patients were at high risk, asymptomatic, symptomatic or expressed some personal or family history of gastrointestinal disorders

NHS Economic Evaluation Database.1994